JohnJAcademy.com
Blog

Identification of treatment elements for adolescents with callous unemotional traits: a systematic narrative review

Child Adolesc Psychiatry Ment Health. 2024 Sep 3;18(1):110. doi: 10.1186/s13034-024-00792-2. ABSTRACT Adolescents with callous unemotional (CU) traits are at risk for poor quality-of-life outcomes such …

Recent trends and disparities in 24-hour movement behaviors among US youth with mental, behavioral and neurodevelopmental conditions

J Affect Disord. 2024 Sep 1:S0165-0327(24)01439-3. doi: 10.1016/j.jad.2024.08.209. Online ahead of print. ABSTRACT BACKGROUND: Meeting 24-h movement behaviors (24-HMB: physical activity [PA], screen time [ST], …

Hyperactivation of ATF4/TGF-β1 signaling contributes to the progressive cardiac fibrosis in Arrhythmogenic cardiomyopathy caused by DSG2 Variant

BMC Med. 2024 Sep 4;22(1):361. doi: 10.1186/s12916-024-03593-8. ABSTRACT BACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized with progressive cardiac fibrosis and heart failure. However, …

The impact of intracytoplasmic sperm injection versus conventional in vitro fertilization on the reproductive outcomes of couples with non-male factor infertility and frozen-thawed embryo transfer cycles

Sci Rep. 2024 Sep 3;14(1):20433. doi: 10.1038/s41598-024-71744-1. ABSTRACT This study was aimed to investigate the impact of intracytoplasmic sperm injection (ICSI) on reproductive outcomes in …

Trial of labour after two caesarean sections (TOLA2C) and risk of uterine rupture, a retrospective single centre study

BMC Pregnancy Childbirth. 2024 Sep 3;24(1):576. doi: 10.1186/s12884-024-06763-x. ABSTRACT BACKGROUND: Most German hospitals do not offer a trial of labour after two caesarean sections (TOLA2C). …

Genetic Diagnosis in Neonatal Encephalopathy With Hypoxic Brain Damage Using Targeted Gene Panel Sequencing

J Clin Neurol. 2024 Sep;20(5):519-528. doi: 10.3988/jcn.2023.0500. ABSTRACT BACKGROUND AND PURPOSE: Neonatal encephalopathy (NE) is a neurological syndrome that presents with severe neurological impairments and …

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+)

Neurotherapeutics. 2024 Sep 2:e00378. doi: 10.1016/j.neurot.2024.e00378. Online ahead of print. ABSTRACT ADAPT-SC (NCT04735432) was designed to evaluate noninferiority of subcutaneous (SC) efgartigimod PH20 to intravenous …